Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.
about
Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusionCapillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnosticsIntegrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networksEvaluation of optical detection platforms for multiplexed detection of proteins and the need for point-of-care biosensors for clinical usePhosphoprotein stability in clinical tissue and its relevance for reverse phase protein microarray technology.Pancreatic cancer serum detection using a lectin/glyco-antibody array methodDevelopment of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarkerProteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability.Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterationsSystems approaches to polypharmacology and drug discoveryProtein microarrays and biomarkers of infectious diseaseApplications of protein microarrays for biomarker discovery.A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray.Reverse phase protein arrays: mapping the path towards personalized medicine.The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's diseaseProfiling phospho-signaling networks in breast cancer using reverse-phase protein arraysNew concepts in chronic urticaria.Retinal pigment epithelium (RPE) exosomes contain signaling phosphoproteins affected by oxidative stress.The current state of the art of quantitative phosphoproteomics and its applications to diabetes researchTargeting cancer stem cells with monoclonal antibodies: a new perspective in cancer therapy and diagnosis.The role of proteomics in clinical cardiovascular biomarker discovery.Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chipClinical application of proteomics in ovarian cancer prevention and treatment.Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.A new frontier in personalized cancer therapy: mapping molecular changes.Current advantages in the application of proteomics in inflammatory bowel disease.Individualized therapy for metastatic colorectal cancer.Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.Application of molecular technologies for phosphoproteomic analysis of clinical samples.Detection of phosphorylated insulin receptor in colorectal adenoma and adenocarcinoma: implications for prognosis and clinical outcome.Antibody array analysis with label-based detection and resolution of protein size.Systems pharmacology.Renal cancer: new models and approach for personalizing therapy
P2860
Q26825749-381E2D6D-945D-49FF-BAA0-C1D8720B3234Q28396457-C61BAF86-6A6C-4C00-8B82-6F0A263DF653Q28474080-42D0E124-0F5E-4681-A8CC-F466A7BC87A7Q28652076-D8059AC6-EFFA-497D-A6FE-91ED5B1C3759Q30450696-EB25F0B3-8597-41B2-B71A-775823D09D99Q33391974-393039E3-8B7B-495C-8045-3157C21D000AQ33427212-46B0364F-F542-48BB-ADF9-A21412AE51B1Q33891197-E3B904D8-95F5-46BD-8E44-6D69F13D2249Q33999350-F1C1DEE6-5272-43A0-8C2D-B47F59095718Q34440079-9C04F8D0-C09D-4BFA-9B5A-CE60FA138D85Q34746314-49A029B2-CC7E-458A-862A-FDDA27454A4DQ35002206-BA0C8160-78D1-4211-B28E-F091EC9C4237Q35170387-46EB01E7-A0AC-4ADD-8A53-F1B861051885Q36186223-63030A0C-55D9-46B0-A32E-E49A8BB447BAQ36519831-9322A89B-7003-458C-A54F-EAA3CAF79995Q36660120-77DC883D-C45B-4B93-925B-26D9B2990B7EQ36897569-0A6D802D-EB9F-4AE2-859B-C12093BE57D8Q37029360-4D925CAE-CB1D-4770-9FA8-027EA470ADDFQ37055774-836429EB-7C1B-44CD-A802-5C5A283D3717Q37080936-5DF49826-5603-4893-A632-721361320599Q37206241-02148A0C-E3F7-46A8-BB42-B9CC38162344Q37230702-136B5175-DAA3-4046-93E1-41AD4F2AB7C9Q37294404-BF4CDFB9-DCA3-48B8-A70A-A04F107EEB06Q37605790-44311130-5C2A-4943-B35F-C4EF75EAFA48Q37622475-71D66F2F-DF1D-434F-803E-8CEB967F3F60Q37898108-C9AA964C-62B8-49A7-8163-F6A3FCF18430Q38022190-9F8A4B0E-B5C2-4377-BC6A-17CFCBE96B18Q38092886-EF314649-D7CB-4749-BE02-ACEEE89AF4C7Q38148583-DD5EE869-2342-4747-BA42-8D121CCDCC4EQ38194417-DC29326E-F8A6-407A-AD94-36E2E9632BC9Q38390595-B69C8F2D-D691-4337-AEEA-1EBBA8E963A8Q39939134-1413A185-FCB1-4C86-9FC5-10C38019362BQ41862157-3AED0B4A-F0EE-4B28-906F-2DB9971F3C22Q57160714-818A9A7D-9A41-4BB8-99C0-142C36942FED
P2860
Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reverse-phase protein microarr ...... ry and translational medicine.
@en
type
label
Reverse-phase protein microarr ...... ry and translational medicine.
@en
prefLabel
Reverse-phase protein microarr ...... ry and translational medicine.
@en
P2093
P2860
P356
P1476
Reverse-phase protein microarr ...... ery and translational medicine
@en
P2093
Amy VanMeter
Emanuel F Petricoin
Lance A Liotta
Mariaelena Pierobon
P2860
P304
P356
10.1586/14737159.7.5.625
P577
2007-09-01T00:00:00Z